Titan Pharmaceuticals, Inc.
TTNP
$4.99
$0.091.84%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -31.50% | -68.42% | -58.12% | -58.02% | 3,797.14% |
| Total Receivables | 276.32% | -39.55% | -94.07% | -96.59% | 322.22% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -52.27% | -59.12% | -84.92% | -38.11% | -3.93% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -29.86% | -67.39% | -63.54% | -63.61% | 773.49% |
|
|
|||||
| Total Current Assets | -29.86% | -67.39% | -63.54% | -63.61% | 773.49% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -29.86% | -67.56% | -63.85% | -63.98% | 435.71% |
|
|
|||||
| Total Accounts Payable | -38.48% | -47.71% | -41.95% | -8.85% | -40.37% |
| Total Accrued Expenses | -- | -45.16% | -45.86% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -26.12% | -50.09% | -66.55% | -80.12% | -80.72% |
|
|
|||||
| Total Current Liabilities | -26.12% | -50.09% | -66.55% | -80.12% | -80.72% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -26.12% | -50.09% | -66.55% | -80.12% | -80.72% |
|
|
|||||
| Common Stock & APIC | 0.40% | 0.00% | 0.13% | 0.25% | 2.70% |
| Retained Earnings | -0.71% | -1.07% | -1.20% | -1.51% | -1.40% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -30.20% | -69.18% | -63.27% | -60.28% | 486.17% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | -- |
|
|
|||||
| Total Common Equity | -30.20% | -69.18% | -63.27% | -60.28% | 486.17% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -30.20% | -69.16% | -63.26% | -60.27% | 486.27% |
|
|
|||||